Effectiveness of fractional erbium–YAG laser, microneedling, platelet-rich plasma in localized stable vitiligo patients: randomized clinical trial
Archives of Dermatological Research · 15.06.2024 · 316 (7)
DOI: 10.1007/s00403-024-03035-8 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Archives of Dermatological Research, online erschienen am 15.06.2024. Verfasst von Soheir Abdel-Hamid und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology, and Andrology, Faculty of Medicine, South Valley University, Qena, Egypt. soher.abdel-hamid@med.svu.edu.eg. Hauptthemen laut MEDLINE: Vitiligo, Platelet-Rich Plasma, Lasers, Solid-State, Skin Pigmentation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South Valley University.
Abstract (Originalsprache)
Vitiligo is considered an autoimmune disease, and its treatment is challenging. We assessed and compared the effect of fractional erbium:yttrium–aluminum–garnet (Er:YAG) laser-assisted delivery of platelet-rich plasma versus microneedling (Mn) with platelet-rich plasma (PRP) in enhancing skin repigmentation in localized stable vitiligo patients. In total, 40 patients with localized stable vitiligo were selected in a random manner into two similar groups (20 each). Group (A) was subjected to fractional Er:YAG laser combined with platelet-rich plasma and Group (B) was subjected to microneedling combined with platelet-rich plasma. The procedure was repeated every 2 weeks for up to 6 months. Each individual was assessed clinically utilizing Vitiligo Area Scoring Index (VASI). Fractional Er:YAG + PRP group achieved better pigmentation100% (excellent 30%, very good 15%, good 30% and satisfactory 25%) which is comparable to Mn + PRP where 80% of cases demonstrate repigmentation (20% very good, 10% good and 50% mild). When comparing the VASI scores for both groups after therapy to the baseline VASI, there was a statistically significant decrease [p = 0.001 for group(A) and 0.003 for group(B)]. Regarding the treatment side effects, there was significantly (p = 0.048) side effects among cases treated with microneedling group(B) (25%) than those fractional Er:Yag laser therapy group(A) (5%). Both forms of therapy demonstrated induction of repigmentation of vitiligo, but fractional Er:YAG laser efficacy is greater when combined with platelet-rich plasma. Clinical trials.gov identifier: NCT05511493.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Venereology, and Andrology, Faculty of Medicine, South Valley University, Qena, Egypt. soher.abdel-hamid@med.svu.edu.eg.
- Department of Dermatology, Venereology, and Andrology, Faculty of Medicine, South Valley University, Qena, Egypt.
- Dermatology, Venereology, and Leprosy Hospital, Qena, Egypt.
Förderung
- South Valley University
Zitieren
APA
Abdel-Hamid, S., Ibrahim, H. M., Hameed, A. M., & Hegazy, E. M. (2024). Effectiveness of fractional erbium–YAG laser, microneedling, platelet-rich plasma in localized stable vitiligo patients: randomized clinical trial. Archives of Dermatological Research, 316(7). https://doi.org/10.1007/s00403-024-03035-8
Vancouver
Abdel-Hamid S, Ibrahim HM, Hameed AM, Hegazy EM. Effectiveness of fractional erbium–YAG laser, microneedling, platelet-rich plasma in localized stable vitiligo patients: randomized clinical trial. Archives of Dermatological Research. 2024;316(7). doi:10.1007/s00403-024-03035-8
BibTeX
@article{AbdelHamid2024,
author = {Abdel-Hamid, Soheir and Ibrahim, Hassan M and Hameed, Aya M and Hegazy, Eisa M},
title = {Effectiveness of fractional erbium–YAG laser, microneedling, platelet-rich plasma in localized stable vitiligo patients: randomized clinical trial},
journal = {Archives of Dermatological Research},
year = {2024},
volume = {316},
number = {7},
doi = {10.1007/s00403-024-03035-8}
}
EUVIMED